Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Teva
Moodys
Chubb
McKinsey
Fish and Richardson
Cerilliant
Johnson and Johnson
Novartis

Generated: February 20, 2018

DrugPatentWatch Database Preview

Claims for Patent: 6,699,503

« Back to Dashboard

Summary for Patent: 6,699,503
Title: Hydrogel-forming sustained-release preparation
Abstract:The invention provides a hydrogen-type sustained-release preparation comprising (1) at least one drug, (2) an additive which insures a penetration of water into the core of the preparation and (3) a hydrogen-forming polymer, wherein said preparation is capable of undergoing substantially complete gelation during its stay in the upper digestive tract such as stomach and small intestine and is capable of releasing the drug in the lower digestive tract including colon. By the preparation of the invention, the drug is efficiently released and absorbed even in the colon so that a steady and sustained release effect can be achieved.
Inventor(s): Sako; Kazuhiro (Shizuoka, JP), Nakashima; Hiroshi (Shizuoka, JP), Sawada; Toyohiro (Shizuoka, JP), Okada; Akira (Shizuoka, JP), Fukui; Muneo (Shizuoka, JP)
Assignee: Yamanuchi Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:09/702,880
Patent Claims: 1. A hydrogel-forming sustained-release oral preparation having a gelation index of 70% or more, which comprises: (1) a drug, wherein the amount of said drug is not more than 85% by weight based on the total preparation, (2) a polyethylene glycol which has a solubility such that the volume of water required for dissolving 1 gram of said polyethylene glycol is not more than 5 ml, and wherein the amount of said polyethylene glycol is from 5 to 80% by weight based on the total preparation, and (3) a hydrogel-forming polymer having a viscosity of not less than 1000 cps as measured at 1% concentration in water at 25.degree. C., wherein the amount of said hydrogel-forming polymer is from 10 to 95% by weight based on the total preparation and not less than 70 mg per one preparation.

2. A hydrogel-forming sustained-release oral preparation having a gelation index of 70% or more, which comprises: (1) a drug, wherein the amount of said drug is not more than 85% by weight based on the total preparation, (2) a polyethylene glycol which has a solubility such that the volume of water required for dissolving 1 gram of said polyethylene glycol is not more than 5 ml, and wherein the amount of said polyethylene glycol is from 5 to 80% by weight based on the total preparation, and (3) a polyethylene oxide having a viscosity of not less than 1000 cps as measured at 1% concentration in water at 25.degree. C., wherein the amount of said polyethylene oxide is from 10 to 95% by weight based on the total preparation and not less than 70 mg per one preparation.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Covington
Fuji
Federal Trade Commission
Healthtrust
Mallinckrodt
Fish and Richardson
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot